GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 17 filers reported holding GAIN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 90,000 | $434 | 0.52% |
Greenlight Capital | 546,560 | $2,634,419 | 0.14% |
Wealth Alliance Advisory Group, LLC | 12,502 | $60,260 | 0.02% |
PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $280,042 | 0.02% |
Cannell Capital | 12,371 | $59,628 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $289,200 | 0.01% |
NewEdge Advisors, LLC | 10,500 | $54,075 | 0.00% |
Tower Research Capital LLC (TRC) | 6,844 | $33 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 94,207 | $454,077 | 0.00% |